Memic Innovative Surgery, a medical device company with headquarters in Israel and Florida, received FDA authorization to introduce the first of its kind robotic surgical system that utilizes humanoid-shaped arms to achieve impressive reach and procedural safety. It is intended for benign hysterectomies or the removal of the uterus for non-cancerous conditions along with the
Although in vitro fertilization solely involves a sperm and an egg, the process leading to an embryo can be more challenging than just putting the two together. In 2019, the Centers for Disease Control and Prevention (CDC) reported that approximately 10% of women in the U.S. between the ages of 15-44 had difficulty either getting
Product managers are continuously looking for data and insights to support strategy and to find valuable market information. Companies in industries that are private and guarded find themselves in situations where their questions are usually longer and more complex than possible answers. In 2020 the emerging question is: “what is the impact of COVID-19 in
Gynecologic cancer or reproductive cancer refers to any part of the female reproductive system: cervical, ovarian, uterine, vaginal, and vulvar. The risk of gynecologic cancers increases with age. Like any other type of cancer, gynecology cancer is difficult to detect only by external symptoms; in some cases, early cancer may be detected during clinical exams
Much like during the initial outbreaks of other coronaviruses, there is little certainty regarding the exact effects of COVID-19, especially long-term. However, data about its effects on pregnant women is starting to accumulate and provide preliminary information and precautions. Both the acute and immediate effects of COVID-19 on the mother and child must be considered,
According to the recent market study by iData Research, the total Pelvic Floor Repair market in the U.S. will consequently decline at a -26.9% cumulative growth rate between the years of 2019-2026. The sharp decline is a result of FDA recalls for all transvaginal mesh devices along with a poor reputation of the sacrocolpopexy surgery. Pelvic organ prolapse
Dexcom has announced that its G6 continuous glucose monitoring (CGM) system has won the CE Mark for use during pregnancy and will be available in the United Kingdom as soon as Spring 2020. During pregnancy, hormones that help the baby grow block the mother’s natural production of insulin and can cause insulin resistance. If insulin
IMBiotechnologies Ltd, a medical device company located in Edmonton, Alberta, announced its latest approval from Health Canada. This approval has expanded the use of the organization’s product, the Ekobi Embolization Microspheres. This latest approval allows the microspheres to be used for treating uterine fibroids. IMB’s Ekobi utilizes a minimally invasive technique called embolotherapy, which blocks
The U.S. market for gynecological devices is valued at almost $1.1 billion. Demographic factors, and age are just some of the driving forces that are facilitating change in the gynecology landscape. Assisted reproduction technologies (ART) help women or couples conceive children. Most couples who use ART are affected by infertility, although ART can also be
Register to receive a free U.S. Market Report Suite for Gynecological Devices report synopsis and brochure PATH, a global healthcare organization, and Sinapi Biomedical, a company based in South Africa, have successfully launched Ellavi, the first commercially available, low-cost, fully assembled uterine balloon tamponade that has received internationally-recognized CE marking. In many developing countries, such as those in
